The use of drug metabolism for prediction of intestinal permeability (dagger).

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Pharmaceutics

• Publication date

  2009-01-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/mp8001864PMID 19132929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Use of BDDCS in Classifying the Permeability of Marketed Drugs

  2008cited by this paper
• Effect of Human Renal Cationic Transporter Inhibition on the Pharmacokinetics of Varenicline, a New Therapy for Smoking Cessation: An In Vitro–In Vivo Study

  2008cited by this paper
• Peptide transporter substrate identification during permeability screening in drug discovery: Comparison of transfected MDCK-hPepT1 cells to caco-2 cells

  2007cited by this paper
• Gut instincts: CYP3A4 and intestinal drug metabolism.

  2007cited by this paper
• Intestinal permeability and its relevance for absorption and elimination

  2007cited by this paper
• Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership.

  2007cited by this paper
• Evaluation and suggested improvements of the Biopharmaceutics Classification System (BCS)

  2007cited by this paper
• Identification of influx transporter for the quinolone antibacterial agent levofloxacin.

  2007cited by this paper
• Kinetic determinants of hepatic clearance: Plasma protein binding and hepatic uptake

  2007cited by this paper
• Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.

  2006cited by this paper
• Cilomilast: Orally Active Selective Phosphodiesterase-4 Inhibitor for Treatment of Chronic Obstructive Pulmonary Disease

  2006cited by this paper
• A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.

  2006cited by this paper
• Pharmacokinetic study of memantine in healthy and renally impaired subjects

  2006cited by this paper
• The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension

  2005cited by this paper
• Molecular properties of WHO essential drugs and provisional biopharmaceutical classification.

  2004cited by this paper
• Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

  2004cited by this paper
• Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration

  2004cited by this paper
• Permeability classification of representative fluoroquinolones by a cell culture method.

  2004cited by this paper
• Summary workshop report: biopharmaceutics classification system--implementation challenges and extension opportunities.

  2004cited by this paper
• Biopharmaceutical characterization of sotalol-containing oral immediate release drug products.

  2004cited by this paper
• Identification of Biowaivers Among Class II Drugs: Theoretical Justification and Practical Examples

  2004cited by this paper
• Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.

  2004cited by this paper
• The “High Solubility” Definition of the Current FDA Guidance on Biopharmaceutical Classification System May Be Too Strict for Acidic Drugs

  2004cited by this paper
• Enhanced intestinal absorption of drugs by activation of peptide transporter PEPT1 using proton-releasing polymer.

  2003cited by this paper
• Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers

  2003cited by this paper
• Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions

  2002cited by this paper
• Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease

  2001cited by this paper
• Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors

  2001cited by this paper
• Drug-like properties and the causes of poor solubility and poor permeability.

  2000cited by this paper
• Interactions of Ofloxacin and Erythromycin with the Multidrug Resistance Protein (MRP) in MRP-Overexpressing Human Leukemia Cells

  2000cited by this paper
• Pharmacokinetics and metabolism in early drug discovery.

  1999cited by this paper
• The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver?

  1999cited by this paper
• The fundamental variables of the biopharmaceutics classification system (BCS): a commentary.

  1998cited by this paper
• Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.

  1998cited by this paper
• Link between drug absorption solubility and permeability measurements in Caco-2 cells.

  1998cited by this paper
• Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction.

  1997cited by this paper
• Use of Probe Drugs as Predictors of Drug Metabolism in Humans

  1997cited by this paper
• The Clinical Pharmacokinetics of Levofloxacin

  1997cited by this paper
• Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models

  1997cited by this paper
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability

  1995cited by this paper
• Clinical Pharmacokinetics of Lithium

  1994cited by this paper
• Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.

  1994cited by this paper
• Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.

  1994cited by this paper
• Pharmacokinetic and pharmacodynamic profiles of d-sotalol and d,l-sotalol.

  1993cited by this paper
• Clinical Pharmacokinetics of Fluconazole

  1993cited by this paper
• Loracarbef. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.

  1993cited by this paper
• Pharmacokinetics of Sotalol Enantiomers in Humans

  1992cited by this paper
• Clinical Pharmacokinetics of Metronidazole and Other Nitroimidazole Anti-Infectives

  1992cited by this paper
• Oral Absolute Bioavailability and Intravenous Dose‐Proportionality of Cefprozil in Humans

  1992cited by this paper
• Pharmacokinetics of Cephradine Administered Intravenously and Orally to Young and Elderly Subjects

  1990cited by this paper
• Pharmacokinetics and tissue penetration of fluconazole in humans.

  1990cited by this paper
• Pharmacology, pharmacodynamics and pharmacokinetics of sotalol.

  1990cited by this paper
• Pharmacokinetics of ofloxacin. An overview.

  1989cited by this paper
• Regulation of Whole-Body Leucine Metabolism With Insulin During Mixed-Meal Absorption in Normal and Diabetic Humans

  1988cited by this paper
• Clinical Pharmacokinetics of Valproic Acid — 1988

  1988cited by this paper
• Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem

  1986cited by this paper
• Pharmacokinetics and beta‐blocking effects of timolol in poor and extensive metabolizers of debrisoquin

  1985cited by this paper
• Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size.

  1985cited by this paper
• Human pharmacokinetics and toxicity of high-dose metronidazole administered orally and intravenously.

  1983cited by this paper
• Phenobarbital Pharmacokinetics and Bioavailability in Adults

  1982cited by this paper
• Diazepam absorption

  1982cited by this paper

• Use of surfactant-based amorphous solid dispersions for BDDCS class II drugs to enhance oral bioavailability: A case report of resveratrol.

  2023cites this paper
• Solubility-Permeability Interplay in Facilitating the Prediction of Drug Disposition Routes, Extent of Absorption, Food Effects, Brain Penetration and Drug Induced Liver Injury Potential.

  2023cites this paper
• Citrus, Milk Thistle, and Propolis Extracts Improved the Intestinal Permeability of Curcuminoids from Turmeric Extract─ an In Silico and In Vitro Permeability Caco-2 Cells Approach

  2023cites this paper
• An Overview on Dietary Polyphenols and Their Biopharmaceutical Classification System (BCS)

  2021cites this paper
• In Vitro Human Cell–Based Experimental Models for the Evaluation of Enteric Metabolism and Drug Interaction Potential of Drugs and Natural Products

  2020cites this paper
• Cytotoxic 2‐(2′‐Hydroxyphenyl)benzothiazolylquinoline Analogues and their In Vitro Screening through Developmental Assays †

  2019cites this paper
• An Investigation into the Factors Governing Drug Absorption and Food Effect Prediction Based on Data Mining Methodology

  2019cites this paper
• Drug Classification and Drug Disposition Prediction

  2017cites this paper
• Evaluation of the Intestinal Absorption Mechanism of Casearin X in Caco-2 Cells with Modified Carboxylesterase Activity.

  2016cites this paper
• Caracterização in vitro do metabolismo e da absorção intestinal da casearina X

  2016cites this paper
• In vitro hepatotoxicity and herb-drug interactions of selected African plant extracts

  2016cites this paper
• Predicting Drug Disposition by Integrating In Vitro and In Silico Methodology

  2016cites this paper
• Biopharmaceutics classification system: importance and inclusion in biowaiver guidance

  2015cites this paper
• Selection of Excipients Based on the Biopharmaceutics Classification System of Drugs

  2015cites this paper
• Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS.

  2015cites this paper
• Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome.

  2014cites this paper
• Biowaiver monograph for immediate-release solid oral dosage forms: fluconazole.

  2014cites this paper
• Distinguishing between the Permeability Relationships with Absorption and Metabolism To Improve BCS and BDDCS Predictions in Early Drug Discovery

  2014cites this paper
• Keeping a critical eye on the science and the regulation of oral drug absorption: a review.

  2013cites this paper
• Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements

  2013influential citation
• Regional-Dependent Intestinal Permeability and BCS Classification: Elucidation of pH-Related Complexity in Rats Using Pseudoephedrine

  2013cites this paper
• Intestinal drug transporters: an overview.

  2013cites this paper
• A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.

  2013cites this paper
• Equilibrium solubility versus intrinsic dissolution: characterization of lamivudine, stavudine and zidovudine for BCS classification

  2013cites this paper
• Purely in silico BCS classification: science based quality standards for the world's drugs.

  2013cites this paper
• The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.

  2013cites this paper
• Current regulatory approaches of bioequivalence testing

  2012cites this paper
• The fraction dose absorbed, in humans, and high jejunal human permeability relationship.

  2012cites this paper
• Modelling and simulation in bioequivalence

  2012cites this paper
• Improving the prediction of the brain disposition for orally administered drugs using BDDCS.

  2012cites this paper
• Avaliação da solubilidade e da permeabilidade intestinal de fármacos antirretrovirais. Aplicações na classificação biofarmacêutica

  2012cites this paper
• The Impact of Solubility and Dissolution Assessment on Formulation Strategy and Implications for Oral Drug Disposition

  2012cites this paper
• BIOPHARMACEUTICS DRUG DISPOSITION CLASSIFICATION SYSTEM: AN EXTENSION OF BIOPHARMACEUTICS CLASSIFICA TION SYSTEM

  2012cites this paper
• Case Studies for Practical Food Effect Assessments across BCS/BDDCS Class Compounds using In Silico, In Vitro, and Preclinical In Vivo Data

  2012cites this paper
• Sotalol Permeability in Cultured-Cell, Rat Intestine, and PAMPA System

  2012cites this paper
• Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study.

  2011cites this paper
• Bioequivalence of Oral Products and the Biopharmaceutics Classification System: Science, Regulation, and Public Policy

  2011cites this paper
• Biowaiver monographs for immediate release solid oral dosage forms: levofloxacin.

  2011influential citation
• BDDCS Applied to Over 900 Drugs

  2011cites this paper
• Utility of Physiologically Based Absorption Modeling in Implementing Quality by Design in Drug Development

  2011cites this paper
• The BCS, BDDCS, and Regulatory Guidances

  2011cites this paper
• Biowaiver monographs for immediate release solid oral dosage forms: metronidazole.

  2011cites this paper
• Characterisation and performance assessment of semi-solid dispersions using surface active lipidic carriers

  2011cites this paper
• High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.

  2010cites this paper
• The FDA Should Eliminate the Ambiguities in the Current BCS Biowaiver Guidance and Make Public the Drugs for Which BCS Biowaivers Have Been Granted

  2010cites this paper
• Lääkeaineiden luokittelu biofarmaseuttisten luokittelujärjestelmien mukaan, tapausesimerkki hydroklooritiatsidi

  2010cites this paper
• Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System.

  2010cites this paper
• Generic products of antiepileptic drugs: A perspective on bioequivalence and interchangeability

  2009cites this paper
• Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs

  2009influential citation
• Title The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs Permalink

  2009cites this paper
• The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs

  2009cites this paper